Drugging the undruggable RAS: Mission possible?
AD Cox, SW Fesik, AC Kimmelman, J Luo… - Nature reviews Drug …, 2014 - nature.com
Despite more than three decades of intensive effort, no effective pharmacological inhibitors
of the RAS oncoproteins have reached the clinic, prompting the widely held perception that …
of the RAS oncoproteins have reached the clinic, prompting the widely held perception that …
Genomic instability in cancer: teetering on the limit of tolerance
Cancer genomic instability contributes to the phenomenon of intratumoral genetic
heterogeneity, provides the genetic diversity required for natural selection, and enables the …
heterogeneity, provides the genetic diversity required for natural selection, and enables the …
Variant review with the integrative genomics viewer
JT Robinson, H Thorvaldsdóttir, AM Wenger, A Zehir… - Cancer research, 2017 - AACR
Manual review of aligned reads for confirmation and interpretation of variant calls is an
important step in many variant calling pipelines for next-generation sequencing (NGS) data …
important step in many variant calling pipelines for next-generation sequencing (NGS) data …
[HTML][HTML] Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
C Yang, W Yuan, X Yang, P Li, J Wang, J Han, J Tao… - Molecular cancer, 2018 - Springer
Background Circ-ITCH is a circRNA generated from several exons of itchy E3 ubiquitin
protein ligase (ITCH) and tumor suppressor served as a sponge for certain miRNAs …
protein ligase (ITCH) and tumor suppressor served as a sponge for certain miRNAs …
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We
used the bioinformatics tools' expanding ploidy and allele frequency on nested …
used the bioinformatics tools' expanding ploidy and allele frequency on nested …
Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets
EJ Pietzak, A Bagrodia, EK Cha, EN Drill, G Iyer… - European urology, 2017 - Elsevier
Background Molecular characterization of nonmuscle invasive bladder cancer (NMIBC) may
provide a biologic rationale for treatment response and novel therapeutic strategies …
provide a biologic rationale for treatment response and novel therapeutic strategies …
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders
To assess factors influencing the success of whole-genome sequencing for mainstream
clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families …
clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families …
Non-coding RNA in bladder cancer
Bladder cancer is the tenth most common cancer worldwide and has been associated with
high mortality and morbidity. Although the treatment of bladder cancer is based on well …
high mortality and morbidity. Although the treatment of bladder cancer is based on well …
A new tumor suppressor role for the Notch pathway in bladder cancer
The Notch signaling pathway controls cell fates through interactions between neighboring
cells by positively or negatively affecting the processes of proliferation, differentiation and …
cells by positively or negatively affecting the processes of proliferation, differentiation and …
Modelling bladder cancer in mice: opportunities and challenges
T Kobayashi, TB Owczarek, JM McKiernan… - Nature reviews …, 2015 - nature.com
The prognosis and treatment of bladder cancer have improved little in the past 20 years.
Bladder cancer remains a debilitating and often fatal disease, and is among the most costly …
Bladder cancer remains a debilitating and often fatal disease, and is among the most costly …